Medexus FY27 Q1 adjusted EBITDA climbs 38.2% to US$4.7 million; revenue rises 16.3% to US$28.6 million
Reuters2026/08/10 21:32- Medexus posted net revenue of USD 28.6 million, up 16.3% year over year.
- Operating income climbed to USD 2.1 million, up 133.3% year over year, on increasing operating leverage from GRAFAPEX.
- IFRS net income held at USD 544,000, while adjusted EBITDA rose to USD 4.68 million from USD 3.44 million a year earlier.
- GRAFAPEX product-level net revenue reached USD 4.9 million, exceeding USD 3.2 million of related personnel and infrastructure investments.
- Management reiterated fiscal 2027 GRAFAPEX product-level net revenue outlook of USD 30 million to USD 32 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The higher the yen rises, the more retail investors short! 3.61 trillion yen short bets defy the trend, triggering a short squeeze warning
Even though the yen has reached its highest level in months, Japanese retail investors continue to bet that its sharp rebound will come to an end, and are consistently increasing their short positions.
EUR/USD Price Forecast: Bullish bias remains above 1.1600 ahead of ECB and US inflation
Abraxas Capital hedges $353M ETH short with $32M buy – Here’s why
Pinnacle Silver & Gold outlines fast-track plan to restart El Potrero gold-silver mine in Mexico
Crypto prices
More
